Mural Historical Financial Ratios

MURA Stock   3.63  0.01  0.28%   
Mural Oncology is lately reporting on over 67 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Mural Oncology plc financial condition quickly.
Quick RatioCurrent Ratio
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mural Oncology plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Mural Financial Ratios Analysis

Mural Oncology plcFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Mural Oncology investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Mural financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Mural Oncology history.

Mural Oncology Financial Ratios Chart

At present, Mural Oncology's PTB Ratio is projected to increase slightly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 14.94, whereas Free Cash Flow Yield is forecasted to decline to (1.89).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
JavaScript chart by amCharts 3.21.15201620182020202220240.150.20.250.30.350.40.45 8001K1.2K1.4K1.6K1.8K2K2.2K2.4K 0.740.760.780.80.820.840.860.880.90.92 0.512345678
JavaScript chart by amCharts 3.21.15Payables Turnovertotal: 2.7429091385069917Days Payables Outstandingtotal: 25KIncome Qualitytotal: 10.538875128313377Current Ratiototal: 28.3236485340498

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Income Quality

An assessment of the sustainability of a company's earnings over time, considering factors like revenue source diversification and cost structure.

Current Ratio

A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.
Most ratios from Mural Oncology's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Mural Oncology plc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mural Oncology plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
At present, Mural Oncology's PTB Ratio is projected to increase slightly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 14.94, whereas Free Cash Flow Yield is forecasted to decline to (1.89).

Mural Oncology fundamentals Correlations

0.990.95-0.95-0.761.0-0.950.45-0.930.711.0-0.940.94-0.94-0.8-0.52-1.01.0-0.930.971.00.921.00.990.990.99
0.990.97-0.94-0.80.99-0.930.54-0.890.631.0-0.950.97-0.95-0.74-0.5-1.01.0-0.950.991.00.951.01.01.01.0
0.950.97-0.93-0.810.95-0.920.68-0.870.470.96-0.981.0-0.98-0.6-0.56-0.970.96-0.980.990.961.00.960.970.970.97
-0.95-0.94-0.930.59-0.951.0-0.410.99-0.64-0.940.98-0.90.970.730.740.95-0.950.96-0.93-0.95-0.9-0.94-0.94-0.94-0.94
-0.76-0.8-0.810.59-0.760.58-0.650.51-0.42-0.790.66-0.820.660.51-0.030.78-0.780.68-0.82-0.78-0.82-0.79-0.79-0.8-0.8
1.00.990.95-0.95-0.76-0.950.45-0.930.711.0-0.940.94-0.94-0.8-0.52-1.01.0-0.930.971.00.921.00.990.990.99
-0.95-0.93-0.921.00.58-0.95-0.40.99-0.64-0.930.97-0.90.970.740.750.95-0.940.96-0.92-0.94-0.89-0.94-0.93-0.93-0.93
0.450.540.68-0.41-0.650.45-0.4-0.27-0.290.52-0.60.72-0.60.15-0.26-0.510.49-0.630.640.490.750.510.530.540.54
-0.93-0.89-0.870.990.51-0.930.99-0.27-0.71-0.90.93-0.830.930.790.750.92-0.910.92-0.87-0.91-0.82-0.91-0.9-0.89-0.89
0.710.630.47-0.64-0.420.71-0.64-0.29-0.710.65-0.480.43-0.48-0.99-0.18-0.660.68-0.450.540.680.390.660.640.630.63
1.01.00.96-0.94-0.791.0-0.930.52-0.90.65-0.940.96-0.95-0.75-0.5-1.01.0-0.940.991.00.941.01.01.01.0
-0.94-0.95-0.980.980.66-0.940.97-0.60.93-0.48-0.94-0.961.00.60.720.95-0.941.0-0.96-0.94-0.96-0.94-0.95-0.95-0.95
0.940.971.0-0.9-0.820.94-0.90.72-0.830.430.96-0.96-0.96-0.56-0.53-0.960.95-0.970.990.951.00.960.960.970.97
-0.94-0.95-0.980.970.66-0.940.97-0.60.93-0.48-0.951.0-0.960.60.720.95-0.951.0-0.96-0.95-0.96-0.94-0.95-0.95-0.95
-0.8-0.74-0.60.730.51-0.80.740.150.79-0.99-0.750.6-0.560.60.260.76-0.770.57-0.65-0.77-0.52-0.76-0.74-0.74-0.74
-0.52-0.5-0.560.74-0.03-0.520.75-0.260.75-0.18-0.50.72-0.530.720.260.52-0.510.71-0.52-0.51-0.54-0.5-0.5-0.5-0.5
-1.0-1.0-0.970.950.78-1.00.95-0.510.92-0.66-1.00.95-0.960.950.760.52-1.00.95-0.99-1.0-0.94-1.0-1.0-1.0-1.0
1.01.00.96-0.95-0.781.0-0.940.49-0.910.681.0-0.940.95-0.95-0.77-0.51-1.0-0.940.981.00.931.01.01.01.0
-0.93-0.95-0.980.960.68-0.930.96-0.630.92-0.45-0.941.0-0.971.00.570.710.95-0.94-0.97-0.94-0.97-0.94-0.94-0.95-0.95
0.970.990.99-0.93-0.820.97-0.920.64-0.870.540.99-0.960.99-0.96-0.65-0.52-0.990.98-0.970.980.980.990.990.990.99
1.01.00.96-0.95-0.781.0-0.940.49-0.910.681.0-0.940.95-0.95-0.77-0.51-1.01.0-0.940.980.931.01.01.01.0
0.920.951.0-0.9-0.820.92-0.890.75-0.820.390.94-0.961.0-0.96-0.52-0.54-0.940.93-0.970.980.930.940.950.950.95
1.01.00.96-0.94-0.791.0-0.940.51-0.910.661.0-0.940.96-0.94-0.76-0.5-1.01.0-0.940.991.00.941.01.01.0
0.991.00.97-0.94-0.790.99-0.930.53-0.90.641.0-0.950.96-0.95-0.74-0.5-1.01.0-0.940.991.00.951.01.01.0
0.991.00.97-0.94-0.80.99-0.930.54-0.890.631.0-0.950.97-0.95-0.74-0.5-1.01.0-0.950.991.00.951.01.01.0
0.991.00.97-0.94-0.80.99-0.930.54-0.890.631.0-0.950.97-0.95-0.74-0.5-1.01.0-0.950.991.00.951.01.01.0
Click cells to compare fundamentals

Mural Oncology Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Mural Oncology plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mural Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mural Oncology Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mural Oncology Plc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mural Oncology plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.03)
Return On Assets
(0.85)
Return On Equity
(1.84)
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.